Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.

Rebecca Wilkes's Articles

Immunocore and Genentech Expand Partnership to Develop Cancer Immunotherapy MEDICAL

Immunocore and the US biotech giant Genentech are building on their existing partnership to boost the clinical development of Immunocore’s immunotherapy for treating solid tumors.

Leading recruitment agency assembles new Operations Team to spearhead its ‘next generation flexible work model’

SRG, the leading science, clinical and engineering recruitment agency, is today announcing a new operational leadership team for Synergy, its flexible science insourcing service dubbed the ‘next generation flexible work model’. 

Induced Pluripotent Stem Cells for Regenerative Research

AMSBIO announces that induced pluripotent stem (iPS) cell expert - Dr Masato Nakagawa from the Nobel Prize winning Yamanaka Lab** at the Centre for iPS Cell Research and Application, Kyoto University, Japan will give 3 talks in the UK on the 10th and 11th December 2018.

AMSBIO Expand Range of FFPE Cancer Cell Line Controls

AMSBIO has expanded its range of high quality FFPE cancer cell line controls for immunohistochemistry (IHC), in situ hybridization (ISH) and Next Generation Sequencing (NGS) applications.

Evox Therapeutics has secured £655,000 in funding from Duchenne UK

Evox Therapeutics has secured £655,000 in funding from Duchenne UK, to support exploration of its exosome-based therapeutic platform for the condition.Duchenne is a highly debilitating, progressive, muscle-wasting disorder caused by the lack of functional dystrophin protein, for which there is currently no cure.

Abingdon Health launches App that transforms a Smartphone into a rapid analytical tool

13 November 2018: BioHub Birmingham® tenant Abingdon Health has launched an intuitive software application called AppDx. AppDx enables a Smartphone to ‘read’ lateral flow test lines, using the inbuilt camera, which translates the image into numerical data.  

Diamond Win Two Categories in the 2018 TOPRA Awards

Diamond Pharma Services Ltd (“Diamond”), a leading technical services and regulatory affairs consulting group, providing expert support and advice to pharmaceutical and biotechnology companies, has received both the Futures and Support Award at The Organisation for Professionals in Regulatory Affairs (TOPRA) Awards.

Absolute Antibody Opens New Facility to Support Continued Growth of its Recombinant Antibody Technology

Absolute Antibody specialises in recombinant antibody products and services. All of our manufacturing takes place in the UK, but over 70% of our revenue comes from international exports. This expansion will allow us to meet growing global demand for recombinant antibody technology across the pharmaceutical, diagnostics, and academic sectors.

Leading AI-driven drug discovery company Exscientia expands to The Oxford Science Park

Oxford, UK, 1 November 2018 - In a key point in its growth strategy, Exscientia, the innovative company at the forefront of Artificial Intelligence (AI)-driven drug discovery, is expanding its Oxford presence to the new Schrödinger Building on The Oxford Science Park, one of the UK's leading parks for science and technology companies.

New lab facility for life science companies to open on Newcastle Helix

The Biosphere will provide a home for ambitious companies within life sciences and innovation, research and development. The new 90,000 sq. ft purpose-built £25m facility will contain both commercial laboratory and office spaces. As well as satisfying commercial laboratory demand, a conferencing facility for up to 80 people will offer a space for an events programme and for the sector to meet and share knowledge. The building is due for completion late November 2018.

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.